Oruka Therapeutics, Inc. (ORKA)
Healthcare
Biotechnology
94.80 $
-1.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Oruka Therapeutics, Inc. (ORKA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -88 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.3 | -9.4 | -11 | -15 | -17 | -8.2 | -4.8 | -7.7 | -19 | -11 | -58 | -88 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | |
| – | – | – | – | – | – | – | – | – | – | – | 24 | |
| 1.3 | -0.4 | 0.1 | 0.4 | 0.1 | -0.6 | 0.4 | 1.9 | 0.0 | -1.7 | 12 | -2.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | |
| 0.0 | 0.0 | 0.0 | -16 | 13 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | -330 | -97 | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0 | |
| 19 | 8.0 | 34 | – | 5.8 | 3.1 | 6.6 | 48 | 23 | – | 450 | 170 | |
| 14 | -1.4 | 23 | -31 | 1.3 | -2.1 | 1.8 | 41 | 4.3 | -11 | 24 | -15 | |
| -5.3 | -9.4 | -11 | -15 | -17 | -8.2 | -4.8 | -7.7 | -19 | -11 | -58 | -88 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.